Basic and clinical neuroscience · 2020
COVID-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. An International Society of Addiction Medicine Practice and Policy Interest Group Position Paper.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Farhoudian Ali, Baldacchino Alexander, Clark Nicolas, Gerra Gilberto, Ekhtiari Hamed, Dom Geert, Mokri Azarakhsh, Sadeghi Mandana, Nematollahi Pardis, Demasi Maryanne, Schütz Christian G, Hash-Emian Seyed Mohammadreza, Tabarsi Payam, Galea-Singer Susanna, Carrà Giuseppe, Clausen Thomas, Kouimtsidis Christos, Tolomeo Serenella, Radfar Seyed Ramin, Razaghi Emran Mohammad
Аннотация
Coronavirus Disease 2019 (COVID-19) is escalating all over the world and has higher morbidities and mortalities in certain vulnerable populations. People Who Use Drugs (PWUD) are a marginalized and stigmatized group with weaker immunity responses, vulnerability to stress, poor health conditions, high-risk behaviors, and lower access to health care services. These conditions put them at a higher risk of COVID-19 infection and its complications. In this paper, an international group of experts on addiction medicine, infectious diseases, and disaster psychiatry explore the possible raised concerns in this issue and provide recommendations to manage the comorbidity of COVID-19 and Substance Use Disorder (SUD).